These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33768760)

  • 21. The impact of female fetal sex on preeclampsia and the maternal immune milieu.
    Taylor BD; Ness RB; Klebanoff MA; Tang G; Roberts JM; Hougaard DM; Skogstrand K; Haggerty CL
    Pregnancy Hypertens; 2018 Apr; 12():53-57. PubMed ID: 29674199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction.
    Illanes S; Parra M; Serra R; Pino K; Figueroa-Diesel H; Romero C; Arraztoa JA; Michea L; Soothill PW
    Prenat Diagn; 2009 Dec; 29(12):1118-22. PubMed ID: 19816882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating Total Cell-Free DNA Levels Are Increased in Hypertensive Disorders of Pregnancy and Associated with Prohypertensive Factors and Adverse Clinical Outcomes.
    Amaral LM; Sandrim VC; Kutcher ME; Spradley FT; Cavalli RC; Tanus-Santos JE; Palei AC
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33429954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.
    Adekola H; Romero R; Chaemsaithong P; Korzeniewski SJ; Dong Z; Yeo L; Hassan SS; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2015; 28(14):1621-32. PubMed ID: 25211383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
    Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fetal sex dependency of maternal vascular adaptation to pregnancy: a prospective population-based cohort study.
    Broere-Brown ZA; Schalekamp-Timmermans S; Hofman A; Jaddoe V; Steegers E
    BJOG; 2016 Jun; 123(7):1087-95. PubMed ID: 26179828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between maternal body mass index and pregnancy outcomes in twin compared with singleton pregnancies.
    Ram M; Berger H; Lipworth H; Geary M; McDonald SD; Murray-Davis B; Riddell C; Hasan H; Barrett J; Melamed N;
    Int J Obes (Lond); 2020 Jan; 44(1):33-44. PubMed ID: 30992520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterizing placental stiffness using ultrasound shear-wave elastography in healthy and preeclamptic pregnancies.
    Spiliopoulos M; Kuo CY; Eranki A; Jacobs M; Rossi CT; Iqbal SN; Fisher JP; Fries MH; Kim PCW
    Arch Gynecol Obstet; 2020 Nov; 302(5):1103-1112. PubMed ID: 32676857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia.
    Zhong XY; Holzgreve W; Hahn S
    Hypertens Pregnancy; 2002; 21(1):77-83. PubMed ID: 12044339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-Free Foetal DNA as a Useful Marker for Preeclampsia Prediction.
    Karapetian АО; Baev ОR; Sadekova АА; Krasnyi АМ; Sukhikh GT
    Reprod Sci; 2021 May; 28(5):1563-1569. PubMed ID: 33475978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal trends in fetoplacental biochemical markers, uterine artery pulsatility index and maternal blood pressure during the first trimester of pregnancy.
    Wortelboer EJ; Koster MP; Kuc S; Eijkemans MJ; Bilardo CM; Schielen PC; Visser GH
    Ultrasound Obstet Gynecol; 2011 Oct; 38(4):383-8. PubMed ID: 21520474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-Free Total and Fetal DNA in First Trimester Maternal Serum and Subsequent Development of Preeclampsia.
    Silver RM; Myatt L; Hauth JC; Leveno KJ; Peaceman AM; Ramin SM; Samuels P; Saade G; Sorokin Y; Clifton RG; Reddy UM
    Am J Perinatol; 2017 Jan; 34(2):191-198. PubMed ID: 27398706
    [No Abstract]   [Full Text] [Related]  

  • 33. First-trimester preterm preeclampsia prediction with metabolite biomarkers: differential prediction according to maternal body mass index.
    Tuytten R; Syngelaki A; Thomas G; Panigassi A; Brown LW; Ortea P; Nicolaides KH
    Am J Obstet Gynecol; 2023 Jul; 229(1):55.e1-55.e10. PubMed ID: 36539025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
    Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dynamics of extracellular DNA associates with treatment response in patients with rheumatoid arthritis.
    Macáková K; Illésová J; Mlynáriková V; Lesayová A; Konečná B; Vlková B; Celec P; Šteňová E
    Sci Rep; 2022 Dec; 12(1):21099. PubMed ID: 36473902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal cord plasma lipoprotein status in uncomplicated human pregnancies and in pregnancies complicated by pre-eclampsia and intrauterine growth restriction.
    Rodie VA; Caslake MJ; Stewart F; Sattar N; Ramsay JE; Greer IA; Freeman DJ
    Atherosclerosis; 2004 Sep; 176(1):181-7. PubMed ID: 15306192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure.
    Galeva S; Gil MM; Konstantinidou L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):804-809. PubMed ID: 30977206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SRY-specific cell free fetal DNA in maternal plasma in twin pregnancies throughout gestation.
    Orendi K; Klein K; Krampl-Bettelheim E; Nuk M; Holzapfel-Bauer M; Magnet E; Griesbacher A; Lang U; Pertl B
    Placenta; 2011 Aug; 32(8):611-5. PubMed ID: 21696822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
    O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction.
    Alberry MS; Maddocks DG; Hadi MA; Metawi H; Hunt LP; Abdel-Fattah SA; Avent ND; Soothill PW
    Am J Obstet Gynecol; 2009 Jan; 200(1):98.e1-6. PubMed ID: 19121662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.